GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India · Delayed Price · Currency is INR 2,550.20
+36.95 (1.47%)
At close: Jul 27, 2026
BOM:500660 Market Cap
BOM:500660 has a market cap or net worth of 432.02 billion as of July 27, 2026. Its market cap has decreased by -19.16% in one year.
Market Cap
432.02B
Enterprise Value
404.78B
Revenue
38.22B
Ranking
n/a
PE Ratio
41.70
Stock Price
2,550.20
ChartMarket Cap Chart
Since October 25, 2001, BOM:500660's market cap has increased from 19.14B to 432.02B, an increase of 2,157.15%. That is a compound annual growth rate of 13.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 432.02B | 3.21% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.08T |
| Dr. Reddy's Laboratories | 960.10B |
| Abbott India | 595.05B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 250.45B |
| Granules India | 206.58B |
| AstraZeneca Pharma India | 200.00B |
| Caplin Point Laboratories | 187.34B |